Serum endocan levels in patients with chronic obstructive pulmonary disease: a potential role in the evaluation of susceptibility to exacerbation-Reference-Cited by-同舟云学术

Serum endocan levels in patients with chronic obstructive pulmonary disease: a potential role in the evaluation of susceptibility to exacerbation

Published:2018-11-27 Issue:12 Volume:56 Page:e295-e297
ISSN:1437-4331
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:
Short-container-title:

Author:

Kechagia Maria,Michalakakou Kalliopi,Griniouk Khristina,Piante Andriani,Karagiannidis Napoleon,Filaditaki Vassiliki,Daniil Zoe,Papassotiriou Ioannis,Gourgoulianis Konstantinos I.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2018-0331/pdf

Reference18 articles.

1. Longitudinal measurement of serum vascular endothelial growth factor in patients with chronic obstructive pulmonary disease;Respiration,2015

2. Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD;COPD,2013

3. Identification of a 14 kDa endocan fragment generated by cathepsin G a novel circulating biomarker in patients with sepsis;J Pharm Biomed Anal,2013

4. The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD);Respir Res,2017

5. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines;J Biol Chem,1996

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?;Journal of Clinical Medicine;2020-02-09